ABSTRACT
INTRODUCTION
The resistance of E. coli to various antibiotics has been widely reported. Escherichia coli is a rod-shaped gramnegative bacteria in single cells or in pairs, the normal intestinal flora that contributes to the normal function of intestine and nutrients, but will be pathogenic bacteria when it reaches the tissue outside intestinal tissue. Hospitalized patients with hematologic malignancies had a great risk for an infection, even life-threatening sepsis. The microorganisms that cause the infection may be endogenous, deriving from the patient's body, or from the transmission of infection of other patients who are also being treated in the hospital. Most of the causes of infection are derived from bacterial colonies found in the intestine, which can ultimately lead to severe sepsis or death (Rena et al 2010) .
Clinical manifestations of E. coli infection depend on the area of infection and cannot be distinguished from symptoms caused by the other bacteria (Holt et al 1994 , Forbes et al 2006 . The presence of different patterns of bacteria in each respective environment makes it more difficult to give empiric antibiotics. By collecting data about microbials pattern that corresponds to the surrounding environment is a way to reduce the occur-rence of infections in patients with hematologic malignancies, and simultaneously suppress the incidence of bacteria resistance to the pre-existing antibiotic (Nilsson et al 2003) . The purpose of this study was to determine the development of resistance of the Escherichia coli obtained from rectal swab cultures of patients with pediatric hematologic malignancies in Pediatric Hemato-Oncology Ward, Dr. Soetomo Hospital Surabaya.
MATERIALS AND METHODS
This research was a descriptive study of the secondary data held in the pediatric hematology-oncology ward in Dr. Soetomo Hospital Surabaya. The population was patients who had been treated in Pediatric HematoOncology ward and had antibiotic sensitivity test results from rectal swab culture. The sample was patients who had antibiotic sensitivity test results from the rectal swab culture containing the growth of Escherichia coli in the ward during the period of October 2012 -March 2013. Exclusion criteria were patients who have rectal swab cultures containing the growth of Escherichia coli but do not have the sensitivity test results, incomplete and illegible medical records, or unclear and illegible susceptibility test results.
RESULTS
Data were obtained from medical records and patient registration data of pediatric hematology-oncology ward patients who had antibiotic sensitivity test results from rectal swab cultures containing the growth of Escherichia coli in October 2012 -March 2013, as many as 20 subjects. showed the highest resistance to cotrimoxazole (80%). (Table 1) . Four Escherichia coli cultures were found with ESBL (extended-spectrum -lactamase). The results of this study showed that ESBL E. coli was sensitive to antibiotics meropenem (100%). Although being a normal flora, which is safe and does not cause health problems, E. coli can still cause some problems in patients with decreased immunity, due to malignancy of the disease itself or due to sitostatics that lead the patient more susceptible to infection, which is known as immunocompromised. This situation may result in the patient becomes infected by microorganisms either from his own body or from outside.
The results of this study showed a high resistance of E. coli obtained from rectal swab cultures of pediatric patients with hematologic malignancies. This study reported that E. coli, a normal flora of the gastrointestinal tract, turned out to have resistance to cotrimoxazole, ampicillin sulbactam, and -lactam class Ampicillin. Antibiotics should be used with caution because E. coli has mechanism of resistance on genes of extended-spectrum -lactamase (ESBL). It is consistent with the results obtained in this study, that there were four cultures showing Escherichia coli with ESBL properties.
CONCLUSION
Escherichia coli in rectal swab culture of hematological malignancies in pediatric patients have resistance to cotrimoxazole, ampicillin, sulbactam and ampicillin.
